Advances in the prevention and treatment of Mycobacterium avium disease

Editorial

C R Horsburgh Jr. N Engl J Med. 1996.

. 1996 Aug 8;335(6):428-30.

doi: 10.1056/NEJM199608083350610.

No abstract available

Comment in

Viral load and combination therapy for human immunodeficiency virus.
Feder HM Jr, Milch LR. Feder HM Jr, et al. N Engl J Med. 1997 Mar 27;336(13):959-60; author reply 960. N Engl J Med. 1997. PMID: 9072698 No abstract available.

A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
Pierce M, Crampton S, Henry D, Heifets L, LaMarca A, Montecalvo M, Wormser GP, Jablonowski H, Jemsek J, Cynamon M, Yangco BG, Notario G, Craft JC. Pierce M, et al. N Engl J Med. 1996 Aug 8;335(6):384-91. doi: 10.1056/NEJM199608083350603. N Engl J Med. 1996. PMID: 8663871 Clinical Trial.
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Shafran SD, Singer J, Zarowny DP, Phillips P, Salit I, Walmsley SL, Fong IW, Gill MJ, Rachlis AR, Lalonde RG, Fanning MM, Tsoukas CM. Shafran SD, et al. N Engl J Med. 1996 Aug 8;335(6):377-83. doi: 10.1056/NEJM199608083350602. N Engl J Med. 1996. PMID: 8676931 Clinical Trial.
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC Jr, Witt MD, Bozzette SA, McCutchan JA. Havlir DV, et al. N Engl J Med. 1996 Aug 8;335(6):392-8. doi: 10.1056/NEJM199608083350604. N Engl J Med. 1996. PMID: 8676932 Clinical Trial.

Mycobacterium avium intracellulare otomastoiditis: case report and literature review.
Muller B, Kemper J, Hartwig NG, Mooi-Kokenberg EA, van Altena R, Versteegh FG. Muller B, et al. Eur J Clin Microbiol Infect Dis. 2006 Nov;25(11):723-7. doi: 10.1007/s10096-006-0218-8. Eur J Clin Microbiol Infect Dis. 2006. PMID: 17061096 Review.
Saquinavir. Clinical pharmacology and efficacy.
Vella S, Floridia M. Vella S, et al. Clin Pharmacokinet. 1998 Mar;34(3):189-201. doi: 10.2165/00003088-199834030-00002. Clin Pharmacokinet. 1998. PMID: 9533981 Review.
The role of advanced generation macrolides in the prophylaxis and treatment of Mycobacterium avium complex (MAC) infections.
Amsden GW, Peloquin CA, Berning SE. Amsden GW, et al. Drugs. 1997 Jul;54(1):69-80. doi: 10.2165/00003495-199754010-00006. Drugs. 1997. PMID: 9211081 Review.
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease.
Dautzenberg B. Dautzenberg B. Drugs. 1997;54 Suppl 2:1-7; discussion 28-9. doi: 10.2165/00003495-199700542-00003. Drugs. 1997. PMID: 9358194 Review.